Skincare Company Galderma Takes 19K-SF at Miami’s 801 Brickell
By Julia Echikson August 7, 2025 2:35 pm
reprints
Skincare company Galderma signed a 19,000-square-foot lease at Miami’s 801 Brickell office building to establish a U.S. headquarters, sources with knowledge of the deal told Commercial Observer.
The firm — which owns skincare brands Cetaphil and Differin as well as botox alternative Dysport — will occupy the full 22nd floor of the 28-story high-rise, the sources added.
In June, the company, headquartered in Switzerland, announced that it would open a U.S. headquarters to house 150 employees by 2028, without disclosing the footprint of its office.
“The city’s emergence as a premium destination and a trendsetter in areas closely aligned to our activities, as well as its fast-growing healthcare professional community, makes Miami a natural choice for our U.S. headquarters,” Galderma CEO Flemming Ørnskov said in a statement.
Colliers’ Stephen Rutchik and Tom Farmer represented landlords Monarch Alternative Capital and Tourmaline Capital Partners.
Two years ago, the joint venture purchased the 694,863-square-foot 801 Brickell for $250 million. The building counts Mastercard and BNP Paribas as tenants.
Representatives for Galderma and the landlords did not respond to requests for comment.
Julia Echikson can be reached at jechikson@commercialobserver.com.
